脓毒症休克恢复时间缩短与住院费用降低相关
该观察性研究利用美国一家大型学术医院的行政数据,纳入医疗ICU中因脓毒症休克接受血管活性药治疗的587例成人,其中180例(30.7%)院内死亡。采用普通最小二乘线性回归估计ICU停留1天、机械通气1天、血管活性药使用1天及新增肾脏替代治疗相关的增量住院费用。结果显示,脓毒症休克住院费用中位数为98,583美元;ICU停留、机械通气、血管活性药使用各缩短1天分别与费用降低15,670、15,284、17,947美元相关,避免新增肾脏替代治疗与费用降低36,051美元相关。作者认为,缩短器官支持时间和ICU治疗的脓毒症休克疗法可能带来可观的费用节约。
要点
- 脓毒症休克住院费用中位数为98,583美元(IQR 61,177–136,672美元),587例中180例(30.7%)院内死亡。
- ICU停留每缩短1天与费用降低15,670美元(IQR 15,023–16,317美元)相关。
- 机械通气每缩短1天与费用降低15,284美元(IQR 13,566–17,002美元)相关。
- 血管活性药使用每缩短1天与费用降低17,947美元(IQR 16,344–19,549美元)相关。
- 避免新增肾脏替代治疗与费用降低36,051美元(IQR 22,353–49,750美元)相关。
适用人群与场景
- 美国一家大型学术医院医疗ICU中因脓毒症休克接受血管活性药治疗的成人患者,共587例。
研究设计与关键结果
- 观察性研究,利用美国一家大型学术医院的行政数据,纳入587例因脓毒症休克接受血管活性药治疗的成人,其中180例(30.7%)院内死亡。
- 采用普通最小二乘线性回归估计增量住院费用;脓毒症休克住院费用中位数为98,583美元(IQR 61,177–136,672美元)。
- ICU停留缩短1天与费用降低15,670美元(IQR 15,023–16,317美元)相关;机械通气缩短1天与费用降低15,284美元(IQR 13,566–17,002美元)相关。
- 血管活性药使用缩短1天与费用降低17,947美元(IQR 16,344–19,549美元)相关;避免新增肾脏替代治疗与费用降低36,051美元(IQR 22,353–49,750美元)相关。
证据类型、等级与局限
- 证据类型:观察性研究,使用行政数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,缩短器官支持时间和ICU治疗的脓毒症休克疗法可能带来可观的费用节约。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Septic shock therapies that shorten the time to physiologic and clinical recovery may result in financial savings. However, the financial implications of improving these nonmortal outcomes are not well characterized. Therefore, we quantified hospital charges associated with four outcomes: ICU length of stay, duration of invasive mechanical ventilation, duration of vasopressor use, and new renal replacement therapy.
METHODS: This was an observational study using administrative data from a large academic hospital in the United States. The analysis included adults treated with vasopressors for septic shock in a medical ICU. Linear regression modeling with ordinary least square was used to estimate the incremental hospital charges associated with 1 day of ICU length of stay, 1 day of mechanical ventilation, 1 day of vasopressor use, and new renal replacement therapy.
RESULTS: The study population included 587 adults with septic shock, including 180 (30.7%) who died in the hospital. The median charge for a septic shock hospitalization was $98,583 (interquartile range [IQR], $61,177-$136,672). Decreases in ICU length of stay, mechanical ventilation duration, and vasopressor duration of 1 day were associated with charge reductions of $15,670 (IQR, $15,023-$16,317), $15,284 (IQR, $13,566-$17,002), and $17,947 (IQR, $16,344-$19,549), respectively. Avoidance of new renal replacement therapy was associated with a charge reduction of $36,051 (IQR, $22,353-$49,750).
CONCLUSIONS: Septic shock therapies that reduce the duration of organ support and ICU care have the potential to lead to substantial financial savings.
参考来源
- Self WH, Liu D, Strayer N, et al. Charge Reductions Associated With Shorter Time to Recovery in Septic Shock. Chest. 2018. PMID: 30419234. doi:10.1016/j.chest.2018.10.034
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。